222 related articles for article (PubMed ID: 11021534)
1. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein.
Ishido S; Choi JK; Lee BS; Wang C; DeMaria M; Johnson RP; Cohen GB; Jung JU
Immunity; 2000 Sep; 13(3):365-74. PubMed ID: 11021534
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.
Thomas M; Boname JM; Field S; Nejentsev S; Salio M; Cerundolo V; Wills M; Lehner PJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1656-61. PubMed ID: 18230726
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus ubiquitin ligases downregulate cell surface expression of l-selectin.
Kajikawa M; Imaizumi N; Machii S; Nakamura T; Harigane N; Kimura M; Miyano K; Ishido S; Kanamoto T
J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34726593
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication.
Brulois K; Toth Z; Wong LY; Feng P; Gao SJ; Ensser A; Jung JU
J Virol; 2014 Aug; 88(16):9335-49. PubMed ID: 24899205
[TBL] [Abstract][Full Text] [Related]
5. Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells.
Matthews NC; Goodier MR; Robey RC; Bower M; Gotch FM
Eur J Immunol; 2011 Jul; 41(7):1958-68. PubMed ID: 21509779
[TBL] [Abstract][Full Text] [Related]
6. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.
Coscoy L; Ganem D
J Clin Invest; 2001 Jun; 107(12):1599-606. PubMed ID: 11413168
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus.
Thomas M; Wills M; Lehner PJ
Biochem Soc Trans; 2008 Jun; 36(Pt 3):459-63. PubMed ID: 18481981
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins.
Manes TD; Hoer S; Muller WA; Lehner PJ; Pober JS
J Immunol; 2010 May; 184(9):5186-92. PubMed ID: 20357254
[TBL] [Abstract][Full Text] [Related]
10. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases.
Nathan JA; Lehner PJ
Exp Cell Res; 2009 May; 315(9):1593-600. PubMed ID: 19013150
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus.
Mansouri M; Viswanathan K; Douglas JL; Hines J; Gustin J; Moses AV; Früh K
J Virol; 2009 Oct; 83(19):9672-81. PubMed ID: 19605472
[TBL] [Abstract][Full Text] [Related]
12. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
Bartee E; McCormack A; Früh K
PLoS Pathog; 2006 Oct; 2(10):e107. PubMed ID: 17238276
[TBL] [Abstract][Full Text] [Related]
13. Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.
Tomescu C; Law WK; Kedes DH
J Virol; 2003 Sep; 77(17):9669-84. PubMed ID: 12915579
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.
Li Q; Means R; Lang S; Jung JU
J Virol; 2007 Mar; 81(5):2117-27. PubMed ID: 17166914
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Immunol; 1992 Aug; 149(4):1115-23. PubMed ID: 1380031
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.
Ishido S; Wang C; Lee BS; Cohen GB; Jung JU
J Virol; 2000 Jun; 74(11):5300-9. PubMed ID: 10799607
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
Haque M; Ueda K; Nakano K; Hirata Y; Parravicini C; Corbellino M; Yamanishi K
J Gen Virol; 2001 May; 82(Pt 5):1175-1180. PubMed ID: 11297692
[TBL] [Abstract][Full Text] [Related]
18. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.
Riteau B; Rouas-Freiss N; Menier C; Paul P; Dausset J; Carosella ED
J Immunol; 2001 Apr; 166(8):5018-26. PubMed ID: 11290782
[TBL] [Abstract][Full Text] [Related]
19. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity.
Chong AS; Boussy IA; Jiang XL; Lamas M; Graf LH
Cell Immunol; 1994 Aug; 157(1):92-105. PubMed ID: 7518755
[TBL] [Abstract][Full Text] [Related]
20. Human NK cell-mediated cytotoxicity triggered by CD86 and Gal alpha 1,3-Gal is inhibited in genetically modified porcine cells.
Costa C; Barber DF; Fodor WL
J Immunol; 2002 Apr; 168(8):3808-16. PubMed ID: 11937533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
